Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05216666 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty

Study acronym: HSS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 2026 to Dec 2027
    • Study completion date: Dec 2027 to Dec 2028
    v5
  2. Re-verified, no change to tracked fieldsv4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 2022 to May 11, 2022
    • Site details revised
    v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Residual limping after total hip arthroplasty is empirically associated with the use of lateral approach but has been reported in litterature even with the use of posterior approach. The purpose of this clinical trial is to compare the risk of residual limping one year after total hip arthropasty between lateral and posterior approach.
Trial Details
NCT Number NCT05216666
Lead Sponsor Sahlgrenska University Hospital
Collaborators: Vastra Gotaland Region
Conditions
(from sponsor)		 Hip Osteoarthritis, Muscle Weakness, Muscle Atrophy, Muscle Injury, Arthroplasty Complications
Related terms Intermittent Claudication, Muscle Weakness, Muscular Atrophy, Osteoarthritis, Hip
Enrollment 580 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov